HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ACT-709478

a triple T-type calcium channel blocker

Also Known As:

N-(1-((5-cyanopyridin-2-yl)methyl)pyrazol-3-yl)-2-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)acetamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Acetamides: 21
    - ACT-709478: 1
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acetates: 4994
      - Acetamides: 21
        ACT-709478: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - ACT-709478: 1
  - Pyridines: 88
    - ACT-709478: 1

Experts

1.	Dingemanse, Jasper: 1 article (01/2020)
2.	Kaufmann, Priska: 1 article (01/2020)
3.	Kornberger, Rüdiger: 1 article (01/2020)
4.	Ort, Marion: 1 article (01/2020)
5.	Richard, Muriel: 1 article (01/2020)

Related Diseases

1.	Epilepsy (Aura) 01/01/2020 - "ACT-709478 is a selective, orally available T-type calcium channel blocker being studied as a potential new treatment in epilepsy. "

Related Drugs and Biologics

1.	T-Type Calcium Channels (T-Type Calcium Channel)